1-109923252-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000329608.11(CSF1):c.631C>T(p.Leu211Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00113 in 1,604,738 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000329608.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF1 | NM_000757.6 | c.631C>T | p.Leu211Phe | missense_variant | 6/9 | ENST00000329608.11 | NP_000748.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF1 | ENST00000329608.11 | c.631C>T | p.Leu211Phe | missense_variant | 6/9 | 1 | NM_000757.6 | ENSP00000327513.6 |
Frequencies
GnomAD3 genomes AF: 0.000749 AC: 114AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000573 AC: 139AN: 242532Hom.: 0 AF XY: 0.000681 AC XY: 89AN XY: 130648
GnomAD4 exome AF: 0.00117 AC: 1701AN: 1452440Hom.: 3 Cov.: 30 AF XY: 0.00120 AC XY: 863AN XY: 721794
GnomAD4 genome AF: 0.000749 AC: 114AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000685 AC XY: 51AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.631C>T (p.L211F) alteration is located in exon 1 (coding exon 1) of the CSF1 gene. This alteration results from a C to T substitution at nucleotide position 631, causing the leucine (L) at amino acid position 211 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at